Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Body mass index changes after the initiations of sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: LIN, Yi-Han (Chang Gung Memorial Hospital, Keelung, Taiwan, Department of Pharmacy, Keelung city, China Taiwan)
- Co-author(s): Yung-Chi Lin:
Shih-Chieh Shao: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan,
Yuk-Ying Chan: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan,
BackgroundThe real-world evidence on the body mass index (BMI) changes of sodium glucose co-transporter 2 inhibitors (SGLT2i) remained uncertain.
PurposeTo investigate the SGLT2i treatment effects on BMI in patients with T2DM in Taiwan.
MethodsWe conducted the retrospective cohort study from May to December 2016 in one regional hospital in Taiwan... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019